Published :
Tables : 49
Figures : 44
Category : Healthcare
No. of Pages : 226
Report Code : HC-1212
Non Invasive Prenatal Testing Market is poised to register a CAGR of 18.1% during the forecast period 2022 to 2028. In non-invasive prenatal testing (NIPT), blood samples from a pregnant woman are tested for abnormalities within the fetus. Test results are analyzed using DNA fragments from the mother's blood in order to diagnose genetic disorders such as Down syndrome , Edwards syndrome , Patau syndrome, and Turner syndrome. This procedure eliminates the need for chorionic villus sampling (CVS), an invasive and precarious procedure, and can be performed at any time after nine weeks of pregnancy. There are growing numbers of genetic disorders of the fetus, which is one of the key factors driving the market's growth. Furthermore, technological advancements in the life sciences and healthcare industries are also driving the market. As an example, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have opened up immense possibilities to combat any serious disease at its earliest stages. Also driving the growth of the market are rising health consciousness and awareness about the importance and benefits of prenatal testing, as well as increasing acceptance and acceptance rates of such tests. It is becoming more common for healthcare providers, as well as expecting parents, to use alternative diagnostic methods to diagnose and treat other genetic disorders, such as spina bifida, cleft palate, and sickle cell anemia. Additionally, the shifting trend toward childbearing at a high maternal age is positively impacting the market growth. There are a number of health complications that can occur as a mother's age advances. These complications can include high blood pressure, reduced fertility, miscarriage risk, and chromosomal abnormalities in the fetus. FutureWise Market Research has instantiated a report that provides an intricate analysis of Non Invasive Prenatal Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Non Invasive Prenatal Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Non Invasive Prenatal Testing (NIPT) Market: • Illumina, Inc. • Thermo Fisher Scientific Inc. • GE Healthcare • Bgi • Agilent Technologies, Inc. • F. Hoffmann-La Roche Ltd. • PerkinElmer Inc. • Laboratory Corporation of America Holdings • Natera, Inc. • Yourgene Health (Note: The list of the major players will be updated with the latest market scenario and trends) Non Invasive Prenatal Testing Market Segmentation: By Product & Service • Products o Consumables o Assay Kits & Reagents o Disposables o Instruments o Ultrasound Devices o Next-Generation Sequencing Systems o Polymerase Chain Reaction Instruments o Microarrays o Other Instruments • Services By Method • Ultrasound Detection • Biochemical Screening Tests • Cell-free DNA in Maternal Plasma Tests By Application • Trisomy • Microdeletion Syndrome • Other Applications By End User • Diagnostic Laboratories • Hospitals By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Non Invasive Prenatal Testing Market Sample Video: Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Non Invasive Prenatal Testing Market By Product & Service, By Method, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansion Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
In non-invasive prenatal testing (NIPT), blood samples from a pregnant woman are tested for abnormalities within the fetus. Test results are analyzed using DNA fragments from the mother's blood in order to diagnose genetic disorders such as Down syndrome , Edwards syndrome , Patau syndrome, and Turner syndrome. This procedure eliminates the need for chorionic villus sampling (CVS), an invasive and precarious procedure, and can be performed at any time after nine weeks of pregnancy. There are growing numbers of genetic disorders of the fetus, which is one of the key factors driving the market's growth. Furthermore, technological advancements in the life sciences and healthcare industries are also driving the market. As an example, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have opened up immense possibilities to combat any serious disease at its earliest stages. Also driving the growth of the market are rising health consciousness and awareness about the importance and benefits of prenatal testing, as well as increasing acceptance and acceptance rates of such tests. It is becoming more common for healthcare providers, as well as expecting parents, to use alternative diagnostic methods to diagnose and treat other genetic disorders, such as spina bifida, cleft palate, and sickle cell anemia. Additionally, the shifting trend toward childbearing at a high maternal age is positively impacting the market growth. There are a number of health complications that can occur as a mother's age advances. These complications can include high blood pressure, reduced fertility, miscarriage risk, and chromosomal abnormalities in the fetus.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Non Invasive Prenatal Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Non Invasive Prenatal Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Non Invasive Prenatal Testing (NIPT) Market: • Illumina, Inc. • Thermo Fisher Scientific Inc. • GE Healthcare • Bgi • Agilent Technologies, Inc. • F. Hoffmann-La Roche Ltd. • PerkinElmer Inc. • Laboratory Corporation of America Holdings • Natera, Inc. • Yourgene Health (Note: The list of the major players will be updated with the latest market scenario and trends)
Non Invasive Prenatal Testing Market Segmentation: By Product & Service • Products o Consumables o Assay Kits & Reagents o Disposables o Instruments o Ultrasound Devices o Next-Generation Sequencing Systems o Polymerase Chain Reaction Instruments o Microarrays o Other Instruments • Services
By Method • Ultrasound Detection • Biochemical Screening Tests • Cell-free DNA in Maternal Plasma Tests
By Application • Trisomy • Microdeletion Syndrome • Other Applications
By End User • Diagnostic Laboratories • Hospitals
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Non Invasive Prenatal Testing Market Sample Video:
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Non Invasive Prenatal Testing Market By Product & Service, By Method, By Application, By End User and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansion
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Non Invasive Prenatal Testing (NIPT) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Non Invasive Prenatal Testing (NIPT) Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Non Invasive Prenatal Testing (NIPT) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Non Invasive Prenatal Testing (NIPT) Market, By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Consumables 7.1.1.1. Assay Kits & Reagents 7.1.1.2. Disposables 7.1.2. Instruments 7.1.2.1. Ultrasound Devices 7.1.2.2. Next-Generation Sequencing Systems 7.1.2.3. Polymerase Chain Reaction Instruments 7.1.2.4 Microarrays 7.1.2.5. Other Instruments 7.2. Services 8. Non Invasive Prenatal Testing (NIPT) Market, By Method Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Ultrasound Detection 8.2. Biochemical Screening Tests 8.3. Cell-free DNA in Maternal Plasma Tests 9. Non Invasive Prenatal Testing (NIPT) Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Trisomy 9.2. Microdeletion Syndrome 9.3. Other Applications 10. Non Invasive Prenatal Testing (NIPT) Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Diagnostic Laboratories 10.2. Hospitals 11. North America Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028 12. Latin America Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028 13. Europe Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028 14. Asia Pacific Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028 16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix 17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Illumina, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Thermo Fisher Scientific Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. GE Healthcare 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Bgi 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies, Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. F. Hoffmann-La Roche Ltd. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. PerkinElmer Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Laboratory Corporation of America Holdings 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Natera, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Yourgene Health 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview 18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations 19. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Non Invasive Prenatal Testing (NIPT) Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Non Invasive Prenatal Testing (NIPT) Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Non Invasive Prenatal Testing (NIPT) Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Non Invasive Prenatal Testing (NIPT) Market, By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Products 7.1.1. Consumables 7.1.1.1. Assay Kits & Reagents 7.1.1.2. Disposables 7.1.2. Instruments 7.1.2.1. Ultrasound Devices 7.1.2.2. Next-Generation Sequencing Systems 7.1.2.3. Polymerase Chain Reaction Instruments 7.1.2.4 Microarrays 7.1.2.5. Other Instruments 7.2. Services
8. Non Invasive Prenatal Testing (NIPT) Market, By Method Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Ultrasound Detection 8.2. Biochemical Screening Tests 8.3. Cell-free DNA in Maternal Plasma Tests
9. Non Invasive Prenatal Testing (NIPT) Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Trisomy 9.2. Microdeletion Syndrome 9.3. Other Applications
10. Non Invasive Prenatal Testing (NIPT) Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Diagnostic Laboratories 10.2. Hospitals
11. North America Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. U.S.A 11.2.2. Canada 11.2.3. Mexico 11.3. Market Size (USD Million) Forecast for North America 2022-2028
12. Latin America Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Brazil 12.2.2. Venezuela 12.2.3. Argentina 12.2.4. Rest of Latin America 12.3. Market Size (USD Million) Forecast for Latin America 2022-2028
13. Europe Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Germany 13.2.2. U.K 13.2.3. France 13.2.4. Italy 13.2.5. Spain 13.2.6. Russia 13.2.7. Poland 13.2.8. Rest of Europe 13.3. Market Size (USD Million) Forecast for Europe 2022-2028
14. Asia Pacific Non Invasive Prenatal Testing (NIPT) Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Japan 14.2.2. China 14.2.3. India 14.2.4. Australia and New Zealand 14.2.5. ASEAN 14.2.6. Rest of Asia Pacific 14.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
15. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. GCC 15.2.2. Israel 15.2.3. South Africa 15.2.4. Rest of MEA 15.3. Market Size (USD Million) Forecast for MEA 2022-2028
16. Market Share Analysis and Competitive Landscape 16.1. Global Landscape - Key Players, Revenue and Presence 16.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 16.3. Global Emerging Companies 16.4. North America - Market Share Analysis and Key Regional Players 16.5. Europe - Market Share Analysis and Key Regional Players 16.6. Asia Pacific - Market Share Analysis and Key Regional Players 16.7. Global Key Player - Growth Matrix
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 17.1. Illumina, Inc. 17.1.1. Company Overview 17.1.2. Product Portfolio 17.1.3. SWOT Analysis 17.1.4. Financial Overview 17.1.5. Strategic Overview 17.2. Thermo Fisher Scientific Inc. 17.2.1. Company Overview 17.2.2. Product Portfolio 17.2.3. SWOT Analysis 17.2.4. Financial Overview 17.2.5. Strategic Overview 17.3. GE Healthcare 17.3.1. Company Overview 17.3.2. Product Portfolio 17.3.3. SWOT Analysis 17.3.4. Financial Overview 17.3.5. Strategic Overview 17.4. Bgi 17.4.1. Company Overview 17.4.2. Product Portfolio 17.4.3. SWOT Analysis 17.4.4. Financial Overview 17.4.5. Strategic Overview 17.5. Agilent Technologies, Inc. 17.5.1. Company Overview 17.5.2. Product Portfolio 17.5.3. SWOT Analysis 17.5.4. Financial Overview 17.5.5. Strategic Overview 17.6. F. Hoffmann-La Roche Ltd. 17.6.1. Company Overview 17.6.2. Product Portfolio 17.6.3. SWOT Analysis 17.6.4. Financial Overview 17.6.5. Strategic Overview 17.7. PerkinElmer Inc. 17.7.1. Company Overview 17.7.2. Product Portfolio 17.7.3. SWOT Analysis 17.7.4. Financial Overview 17.7.5. Strategic Overview 17.8. Laboratory Corporation of America Holdings 17.8.1. Company Overview 17.8.2. Product Portfolio 17.8.3. SWOT Analysis 17.8.4. Financial Overview 17.8.5. Strategic Overview 17.9. Natera, Inc. 17.9.1. Company Overview 17.9.2. Product Portfolio 17.9.3. SWOT Analysis 17.9.4. Financial Overview 17.9.5. Strategic Overview 17.10. Yourgene Health 17.10.1. Company Overview 17.10.2. Product Portfolio 17.10.3. SWOT Analysis 17.10.4. Financial Overview 17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact 18.1. Positive influence on the healthcare industry 18.2. The financial disruption of the manufacturing sector 18.3. Impact of COVID-19 on emerging companies 18.4. Significant mandates in the healthcare regulations initiated by administrations 18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics